• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Heather Danks Named Chief Technology Officer at LEX Diagnostics

    Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech

    South Korean Regulators Authorize Expanded NeuroStar TMS Indications

    Ian T. Meredith Joins Avertix Medical’s Board

    Hologic, Bayer Team Up for Contrast-Enhanced Mammography
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Medtech’s Most Powerful M&A Drivers

    The Link Between Medtech and Connected Medical Devices

    Is the FTC Partly Responsible for Muted M&A Activity?

    Holistic Risk Management: Navigating the Future’s Uncertainties

    Defining End of Life for Medical Devices
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Providence Enterprise USA Inc.

    LEMO USA Inc.

    JBC Technologies

    NDH Medical Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing

    How In Silico Simulations Can Slash Medical Device Development Risk

    The Top 7 AI Applications Transforming Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Providence Enterprise USA Inc.

    LEMO USA Inc.

    JBC Technologies

    NDH Medical Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Extractable/Leachable Chemistry Testing Strategies for Medical Devices

    ...

    Extractable/Leachable Chemistry Testing Strategies for Medical Devices
    Medical device extracts prepared for analysis. Image courtesy of Nelson Laboratories.
    Matthew R Jorgensen, Ph.D., and Thor Rollins, BS, Nelson Laboratories; Allison Komiyama, Ph.D., RAC, AcKnowledge RS04.03.17
    It has become more prevalent and acceptable to use the results of chemistry testing to assess the overall biocompatibility of medical devices. For many devices with prolonged or permanent patient contact, chemistry followed by toxicological assessment can provide a cost and time saving alternative to in vivo tests such as chronic, sub-chronic, genetic, and carcinogenicity testing. Manufacturers preparing to submit their device for approval by the U.S. Food and Drug Administration (FDA) rely on ISO 10993 standards and FDA guidance on the application of those standards in the planning of their chemistry testing. When it comes to the details of chemistry testing, however, the ISO standards are often vague. Furthermore, the recommendations regarding the appropriate level of testing rigor can vary within FDA. The following offers a brief overview of the framework provided by ISO 10993 guidance documents for extractable/leachable (E/L) testing, as well as three testing strategies that satisfy both ISO 10993 and FDA requirements.

    There are three parts of ISO 10993 that are applicable to E/L testing:

    • 10993-12: How to prepare the sample—Defines what an extractable is versus a leachable, the criteria for exhaustive extraction, recommendations on extraction volume and extraction vehicles (polar and non-polar).
    • 10993-18 (BE83:2006/(R)2011): How to analyze the sample—Provides general guidance on the types of analytical instruments appropriate for identification and quantification of different analytes.
    • 10993-17: How to interpret the results—Provides guidance on how to establish allowable limits (tolerable exposures) for substances extracted from medical devices.
    The first step in setting a testing strategy is to establish the goals of the testing and assessment. Typically, the goal of E/L testing is to identify any substance that could leave the device and enter the body, followed by an assessment of whether the substance(s) could result in toxicity to the patient. Therefore, the tests performed should screen for as many compounds as possible, quantify any E/L compounds, and ensure sufficient material is available for assessment.

    Considering that devices commonly contain (intentionally or not) both polar and non-polar substances, and the body is composed of both polar and non-polar fluids and membranes, extraction with both polar and non-polar solvents is required. Water or saline as the polar extraction vehicle and hexane as the non-polar extraction vehicle are commonly accepted choices.

    Although E/L is often used as a substitute for long-term in vivo biocompatibility tests, results are generally considered concurrently with other tests such as cytotoxicity, sensitization, and irritation. To allow comparison to these other tests, similar extraction conditions are recommended, which represent worse-case conditions per ISO 10993-12. Extraction at 50 degrees Celsius for 72 hours is a common first choice. If follow-up testing is required, other conditions more representative of clinical use can be used with justification. Extraction volume should be selected to meet several conditions: the volume should be small enough (resulting in a concentration that is high enough) so the sensitivity of the analysis in terms of µg of analyte per device is acceptable. Additionally, the extraction volume per device should be the same or less than what was used for biocompatibility testing, but still provides enough volume to be practical for all the required analytical tests.

    As mentioned previously, the analysis should screen for as many compounds as possible, as it can be difficult to predict what substances could be on or in a device before analysis. To that end, the analysis should look for both organic and inorganic compounds, be able to identify these compounds, and be able to measure their concentration. Mass spectrometry methods are able to do all of these. Inductively coupled plasma mass spectrometry (ICP/MS) identifies and measures metals (which addresses inorganic compounds), while gas chromatography mass spectrometry (GC/MS) methods identify different classes of organic compounds (provided the molecules are not too large), and liquid chromatography mass spectrometry is used to screen for any organic molecules too large for GC/MS. Therefore, to cast as wide a net as possible, the extracts and their blanks should be analyzed using each of these methods. For a single device, analysis of four liquid samples is involved (one polar, one non-polar, and two blanks), creating a total of 12 mass spectrometry analyses per device. A typical testing matrix is shown in Table 1.


    The analysis in Table 1 represents the most basic E/L analysis strategy: two solvents and two blanks, undergoing a total of 12 analytical tests. Recently, the FDA has requested variations on this analytical strategy that result in increased rigor of the analysis. For example, there have been requests for the addition of a third mid-polarity solvent, such as isopropanol, for the analysis to be repeated in triplicate, or for exhaustive extraction methods to be used. Exhaustive extraction involves repeating the basic extraction and analysis until the currently detected extracts are less than 10 percent of the sum of all extracts; this strategy involves, at a minimum, two analyses but could include more. These strategies are compared in Table 2.


    The cost and turn-around time of E/L testing depends on the lab, but generally scales with the number of analytical tests requested or required. Practices and level of rigor can vary widely in labs performing E/L testing due to the ambiguity of ISO 10993-18. It is critical to determine if the level of rigor meets what is required for toxicological risk assessment per ISO 10993-17. One of the largest variables is whether detected analytes are rigorously quantitated or if they have concentrations that are estimated using semi-quantitative methods. Often, the reality is a combination of both. For example, a lab may report some analytes quantitatively if they are on a panel of common compounds, but only estimate others in a single report. For each analytical method used by a lab, the level of method validation can also vary. Questions of analytical rigor come into play when the chemistry results are interpreted by a toxicologist. If the expert interpreting the results is skilled, they may notice deficiencies in the analytical methodology and be unable to draw a conclusion or make a recommendation other than “more chemistry testing is needed.”

    Selection of a testing strategy should be primarily based upon any specific feedback received from FDA. If no feedback is available, several factors should be considered: the device type, the nature and duration of patient contact, how conservative of an approach is desired, and the cost. FDA may request E/L testing above and beyond the typically required biocompatibility program. For example, we have seen requests for E/L on devices with brightly colored parts, especially when the targeted patient population includes neonates or other sensitive groups. There has also been a trend in requests for exhaustive E/L testing from FDA for devices with respiratory patient contact.

    Approaching E/L chemistry testing can be a daunting task to the uninitiated; there are many variables and the guidance provided by the ISO 10993 standards and FDA is vague. However, a basic analytical protocol (shown in Table 1) has been widely accepted along with extraction conditions that mirror those familiar to biocompatibility testing. Ultimately, the most sure-fire approach is to develop a testing plan in collaboration with the toxicologist interpreting the results and FDA. The recently released FDA guidance document on the use of ISO 10993 stresses the importance of a written biocompatibility evaluation plan (BEP). In this plan, the potential risks of the device should be discussed, as well as the approaches to address the potential risks. The BEP is an excellent place to outline the strategy proposed for E/L chemical analysis and allow FDA to review and comment on the plan as part of a pre-submission conversation. With a nod of approval from FDA and the toxicologist, you can proceed confidently into the world of chemistry. 


    Matthew R. Jorgensen, Ph.D., is a chemistry and materials scientist with Nelson Laboratories. Thor Rollins, B.S., RN (NRCM) is a senior scientist with the company. Allison Komiyama, Ph.D., RAC, is owner and principal consultant at AcKnowledge Regulatory Strategies. 
    Related Searches
    • Medical Devices
    • it
    • validation
    • testing
    Related Knowledge Center
    • Testing
    Suggested For You
    Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products
    Babson Diagnostics Raises $31 Million in Series B Funding Babson Diagnostics Raises $31 Million in Series B Funding
    Picarro Unveils EtO Gas Concentration Analyzer Picarro Unveils EtO Gas Concentration Analyzer
    FDA Clears Inova Diagnostics FDA Clears Inova Diagnostics' Digital Multi-Analyte System
    VitalConnect Launches New Version of VistaCenter for Cardiac & Remote Patient Monitoring VitalConnect Launches New Version of VistaCenter for Cardiac & Remote Patient Monitoring
    Indago Announces $10 Million Financing Close and Name Change Indago Announces $10 Million Financing Close and Name Change
    Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe
    Thermo Fisher Scientific Launches Updated COVID-19 Test Thermo Fisher Scientific Launches Updated COVID-19 Test
    Vicarious Surgical Opens New Corporate Headquarters in Massachusetts Vicarious Surgical Opens New Corporate Headquarters in Massachusetts
    908 Devices Develops New Data Integrations With Key Industry Partners 908 Devices Develops New Data Integrations With Key Industry Partners
    Joint Testing Shows Medical-Grade TPEs Bond Effectively to Copolyesters Joint Testing Shows Medical-Grade TPEs Bond Effectively to Copolyesters
    Roche Roche's COVID-19 Molecular Test Granted EUA
    Westfall Technik Opens New Medical Molding Plant and Clean Room Westfall Technik Opens New Medical Molding Plant and Clean Room
    CorWave Completes Preclinical Study on its Cardiac Pump CorWave Completes Preclinical Study on its Cardiac Pump
    FDA Issues EUA for BD Veritor At-Home Covid-19 Test FDA Issues EUA for BD Veritor At-Home Covid-19 Test

    Related Breaking News

    • Surgical
      Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products

      Olympus Corporation Launches Powerseal Advanced Bipolar Surgical Energy Products

      Deliver consistent sealing reliability in an ergonomic, multifunctional design that promotes procedural efficiency.
      Olympus Corporation 09.21.21

    • Diagnostics
      Babson Diagnostics Raises $31 Million in Series B Funding

      Babson Diagnostics Raises $31 Million in Series B Funding

      Money will be used to help drive commercialization of customer-first, highly accessible diagnostic blood testing.
      Business Wire 09.20.21

    • Picarro Unveils EtO Gas Concentration Analyzer

      Picarro Unveils EtO Gas Concentration Analyzer

      Analyzers are now available for CEMS, stack testing, fenceline, and ambient monitoring systems.
      PR Newswire 09.20.21


    • Diagnostics
      FDA Clears Inova Diagnostics

      FDA Clears Inova Diagnostics' Digital Multi-Analyte System

      The product, Aptiva, received CE marking in August 2020.
      PR Newswire 09.20.21

    • Patient Monitoring
      VitalConnect Launches New Version of VistaCenter for Cardiac & Remote Patient Monitoring

      VitalConnect Launches New Version of VistaCenter for Cardiac & Remote Patient Monitoring

      Brings market-leading patient management and monitoring tools to physicians.
      VitalConnect Inc. 09.16.21

    Loading, Please Wait..

    Trending
    • RJG Names Winners Of 2023 RJG Mold Smart Award
    • Diabetes Innovation: MIT Engineers Unveil Implantable Device With Oxygen Factory
    • A New Approach To Post-Market Surveillance
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    Breaking News
    • Heather Danks Named Chief Technology Officer at LEX Diagnostics
    • Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech
    • South Korean Regulators Authorize Expanded NeuroStar TMS Indications
    • Ian T. Meredith Joins Avertix Medical’s Board
    • Hologic, Bayer Team Up for Contrast-Enhanced Mammography
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Curcumin May Be As Effective as PPI for Indigestion
    Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies
    Women in Nutraceuticals Launches Pilot Mentorship Program
    Coatings World

    Latest Breaking News From Coatings World

    WEG Among the Best Companies in Brazil in 2023
    EMPA Develops Flame Resistant Epoxy Resin
    Becker’s Global Mental Health Program Shows Positive Impact
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Heather Danks Named Chief Technology Officer at LEX Diagnostics
    Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech
    South Korean Regulators Authorize Expanded NeuroStar TMS Indications
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Nexcella Completes 2nd NXC-201 Engineering Batch
    Almirall Upgrades Werum PAS-X MES
    Rentschler Names Industry Veterans to Leadership Posts
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    GK Hair Expands Color Range to 125 Hues
    WPO and AIPIA Sign MoU to Collaborate on Smart Packaging
    SuperstarBots & Skin Match Redefine Personalized Beauty Recommendations with Social Media Chatbot
    Happi

    Latest Breaking News From Happi

    Daniel C. Liebler Wins 2023 RIFM Board of Directors Excellence in Science Award
    NAD Refers SBLA Beauty To Federal Trade Commission
    Altuzza Fashion Show Features Hairstyles by Jawara Using Fekkai Haircare Products
    Ink World

    Latest Breaking News From Ink World

    HYBRID Software’s PrintFusion for Koenig & Bauer
    Fujifilm Announced European Release of the Acuity Prime Hybrid
    Pacific Coatings Show Invites Industry to Top-Class Programs
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Vibrant Labelexpo Europe 2023 concludes in Brussels
    Kenco Label & Tag adds sheeting system from Daco Solutions
    Bastille Parfums strengthens traceability with Avery Dennison RFID technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Lenzing Earns EU Ecolabel at Indonesian Plant
    Albis Starts Up Extra Wide Carding, Blending Line
    Ahlstrom Launches Nonwoven Laundry Care Product
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    AOFAS, Arthritis Foundation Award Grants to Fuel Ankle Arthritis Research
    Lincotek Marks its 50th Anniversary
    FDA OKs Standalone Indication for ChoiceSpine's Blackhawk Ti Cervical Spacer
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Le Biscuit Boosts Omnichannel Operations with Zebra Technologies
    German Government, Bavaria Commit Support to ams OSRAM
    ASSA ABLOY Acquires Evolis

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login